Status:

COMPLETED

Absorption of Insulin Following Subcutaneous Bolus Administration With Different Bolus Durations

Lead Sponsor:

Medical University of Graz

Collaborating Sponsors:

European Commission

Conditions:

Type 1 Diabetes

Eligibility:

All Genders

18-60 years

Phase:

PHASE1

Brief Summary

To cover meal-related insulin requirements, insulin pumps allow insulin to be delivered at high rates over a short period of time (bolus delivery). The length of this period (bolus duration) usually d...

Eligibility Criteria

Inclusion

  • Informed consent obtained after being advised of the nature of the study
  • Male or female aged 18-60 years (both inclusive)
  • Type 1 diabetes treated with multiple daily insulin injection or continuous subcutaneous insulin infusion for 12 months
  • Fasting C-peptide \< 0.3nmol/L
  • Body mass index 20.0-30.0 kg/m² (both inclusive)
  • HbA1c \< 10%

Exclusion

  • Female of childbearing potential who is pregnant, breast-feeding or intend to become pregnant or is not using adequate contraceptive methods
  • Skin pathology or condition prohibiting needle insertion/insulin administration as judged by the investigator
  • History of bleeding disorder
  • Current participation in another clinical study
  • Use of insulin lispro \>2 weeks
  • Significant acute or chronic illness that might interfere with subject safety or integrity of results as judged by the investigator
  • Smoker (defined as \>5 cigarettes/d)
  • Lipodystrophy
  • Current treatment with systemic (oral or i.v.) corticosteroids, monoamine oxidase (MAO) inhibitors, non-selective beta-blockers, growth hormone, herbal products or non-routine vitamins. Furthermore, thyroid hormones are not allowed unless the use of these has been stable during the past 3 months
  • Significant history of alcoholism or drug abuse or a positive result in urine drug/alcohol screen
  • Study Day

Key Trial Info

Start Date :

August 1 2011

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 1 2014

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT01792323

Start Date

August 1 2011

End Date

January 1 2014

Last Update

February 26 2014

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Medical University of Graz

Graz, Styria, Austria, A-8036